X-16786500-G-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_018360.3(TXLNG):c.13G>T(p.Val5Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000314 in 1,114,818 control chromosomes in the GnomAD database, including 1 homozygotes. There are 10 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_018360.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TXLNG | NM_018360.3 | c.13G>T | p.Val5Leu | missense_variant | 1/10 | ENST00000380122.10 | NP_060830.2 | |
TXLNG | NM_001168683.2 | c.13G>T | p.Val5Leu | missense_variant | 1/8 | NP_001162154.1 | ||
TXLNG | XM_047442249.1 | c.13G>T | p.Val5Leu | missense_variant | 1/10 | XP_047298205.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TXLNG | ENST00000380122.10 | c.13G>T | p.Val5Leu | missense_variant | 1/10 | 1 | NM_018360.3 | ENSP00000369465.5 | ||
TXLNG | ENST00000398155.4 | c.13G>T | p.Val5Leu | missense_variant | 1/8 | 1 | ENSP00000381222.4 |
Frequencies
GnomAD3 genomes AF: 0.0000714 AC: 8AN: 112069Hom.: 0 Cov.: 23 AF XY: 0.000117 AC XY: 4AN XY: 34243
GnomAD3 exomes AF: 0.0000536 AC: 3AN: 55961Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 10257
GnomAD4 exome AF: 0.0000269 AC: 27AN: 1002699Hom.: 1 Cov.: 30 AF XY: 0.0000189 AC XY: 6AN XY: 317743
GnomAD4 genome AF: 0.0000714 AC: 8AN: 112119Hom.: 0 Cov.: 23 AF XY: 0.000117 AC XY: 4AN XY: 34303
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 26, 2022 | The c.13G>T (p.V5L) alteration is located in exon 1 (coding exon 1) of the TXLNG gene. This alteration results from a G to T substitution at nucleotide position 13, causing the valine (V) at amino acid position 5 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at